Suppr超能文献

排卵障碍性和不明原因不孕的评估与治疗。

Evaluation and treatment of anovulatory and unexplained infertility.

机构信息

Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.

出版信息

Obstet Gynecol Clin North Am. 2012 Dec;39(4):507-19. doi: 10.1016/j.ogc.2012.09.008.

Abstract

Anovulatory disorders are a primary cause of female infertility. Polycystic ovarian syndrome is the major cause of anovulation and is generally associated with obesity. Lifestyle changes to encourage weight loss are the initial therapy for overweight and obese patients, followed by clomiphene citrate for ovulation induction. For those patients who fail to ovulate on clomiphene citrate, alternatives, such as letrozole; gonadotropins; and complimentary agents to enhance clomiphene citrate, such as metformin and glucocorticoids, are reviewed. Women with unexplained infertility (no identifiable cause of infertility on a routine evaluation) may benefit from ovulation induction with clomiphene citrate, letrozole, or gonadotropins.

摘要

排卵障碍是女性不孕的主要原因。多囊卵巢综合征是排卵障碍的主要原因,通常与肥胖有关。对于超重和肥胖患者,生活方式的改变以鼓励减肥是初始治疗方法,随后是枸橼酸氯米酚促排卵。对于那些对枸橼酸氯米酚无排卵反应的患者,可以选择其他药物,如来曲唑、促性腺激素;以及枸橼酸氯米酚的辅助药物,如二甲双胍和糖皮质激素。对于不明原因不孕的女性(在常规评估中没有发现不孕的原因),枸橼酸氯米酚、来曲唑或促性腺激素促排卵可能会有帮助。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验